December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

67.95 -4.74 (-6.53%)
Streaming Delayed Price Updated: 10:08 AM EDT, Aug 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
From Tempus AI, Inc.
Via Business Wire
News headline image
Why Tempus AI Skyrocketed This Week ↗
Tempus AI's latest acquisition is looking like a great move. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
A Tempus AI Director Sold Stock Four Days Before a 24% Rally. Here's What to Know ↗
West executed a sale under a pre-established Rule 10b5-1 trading plan, reducing her direct stake by 8% while retaining 34,981 shares worth roughly $1.8 million. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
Tempus AI (NASDAQ:TEM) Delivers Mixed Q2 Results with EPS Beat, Stock Slips in After-Hours Trading ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Is Tempus AI Stock a Buy After Its 75% Rally? Here's What to Know as the Firm's Legal Chief Files a Trade ↗
Polovin's sale of 30,075 shares was non-discretionary and tied to tax withholding from RSU vesting. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Accounting Chief Just Reported an Insider Transaction. Here's What Long-Term Investors Should Know ↗
Bartolucci disposed of shares valued at $306,342 to cover statutory withholding obligations tied to RSU vesting, retaining direct holdings of 67,866 shares worth $3.35 million. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
What to Know About the CFO of Tempus AI's Latest Insider Transaction Filing ↗
This non-discretionary sale to cover RSU withholding obligations reduced his direct stake, but he retains about 106,000 shares valued at $6.49 million. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Diagnostics Chief Filed Stock Sales Spanning a Volatile Week. Here's What Happened ↗
These sales were driven by tax withholding obligations tied to restricted stock unit vesting under a pre-established trading plan. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Data Chief Just Filed a Form 4. His Segment Grew 28% Last Quarter. ↗
This sale was non-discretionary, executed to cover tax withholding from RSU vesting. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's CEO Sold $6.6 Million in Stock the Day Before a Huge Rally. Here's What to Know ↗
This filing details a non-discretionary sale that reduced Lefkofsky's direct holdings by a small percentage. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
AI Found an Influenza Target That Survives Viral Mutation
Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT) 
From Equity Insider
Via GlobeNewswire
News headline image
Why Is Tempus AI Stock Surging on Friday? ↗
Tempus AI Inc. (NASDAQ: TEM) stock jumped on Friday, August 7, 2026, following strong AI healthcare peer earnings from Doximity Inc. and a strategic lab expansion with CellCarta. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI Q2 Earnings Call Highlights ↗
Tempus AI (NASDAQ:TEM) reported second-quarter revenue growth of 22% and raised its full-year outlook, citing accelerating oncology testing volumes, expanding demand for its data and artificial... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Tempus AI Stock Slides Friday: What's Driving the Post-Earnings Reset? ↗
Tempus AI Inc. (NASDAQ: TEM) shares are trading lower Friday as traders digest post-earnings reset in expectations. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Is Tempus AI Stock a Buy After Its CEO Sold 250,000 Shares? ↗
Tempus AI's founder-CEO reduced an indirect stake by about 4% through a pre-scheduled trading plan, retaining roughly 6.5 million shares as the company pursues a major acquisition. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus Reports Second Quarter 2026 Results
From Tempus AI, Inc.
Via Business Wire
News headline image
3 Powerful AI Stocks Poised for the Next Massive Shift ↗
AI's next winners may emerge from an overlooked part of the market. See how three software companies are turning proprietary expertise into a potentially powerful growth engine. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine
From Tempus AI, Inc
Via Business Wire
News headline image
Tempus AI Bets on MRD Testing Growth With Personalis Acquisition ↗
Tempus AI (NASDAQ:TEM) executives said the company’s planned acquisition of Personalis is intended to strengthen its position in minimal residual disease, or MRD, testing, while expanding its biopharma... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service
From Tempus
Via Business Wire
News headline image
Tempus to Report Second Quarter 2026 Financial Results on July 30
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
From Tempus AI, Inc.
Via Business Wire
News headline image
Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
From Ambry Genetics
Via Business Wire
News headline image
Great News: This Explosive Healthcare Stock Could Be a Powerful Artificial Intelligence Winner ↗
Tempus AI is growing fast, but the real debate is whether its healthcare data platform can justify the premium price investors are already paying. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
From Tempus AI, Inc.
Via Business Wire
News headline image
Why Tempus AI Stock Is Surging On Thursday? ↗
Tempus AI (NASDAQ: TEM) stock is surging Thursday after launching a first-of-its-kind open-source digital pathology consortium with Yale New Haven Health and MSK. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
From Tempus AI, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.